Info
- Utilizzare la checkbox di selezione a fianco di ciascun documento per attivare le funzionalità di stampa, invio email, download nei formati disponibili del (i) record.
Protein-Ligand Interactions: Target Identification and Drug Discovery
| Protein-Ligand Interactions: Target Identification and Drug Discovery |
| Autore | Altieri Fabio |
| Pubbl/distr/stampa | Basel, Switzerland, : MDPI - Multidisciplinary Digital Publishing Institute, 2021 |
| Descrizione fisica | 1 online resource (184 p.) |
| Soggetto topico |
Chemistry
Research and information: general |
| Soggetto non controllato |
ACE
acetylcholinesterase amyloid beta aggregation brassicasterol cancer cell death cell viability CoCl2 drug development drug discovery endocrine disruptor compound fatty acid conjugation FcRn-mediated recycling fluorescence spectroscopy GADD45β heat shock protein 70 Hsp70 HSV HSV-1 DNA polymerase HSV-1 TK human CDK2 human umbilical artery kinase regulation lipid signalling lipid-protein interaction lung cancer cell line membrane mitochondrial membrane potential MKK7 molecular biophysics molecular docking molecular docking simulation molecular dynamics multi-target drug multiple myeloma Mycobacterium tuberculosis NCI60 COMPARE analysis neuroprotection PGRMC1 phosphatidylinositols phytosterols piperine protein-ligand interaction reactive oxygen species (ROS) serum albumin serum half-life extension sigma ligands sigma receptors SIGMAR1 small-molecule derivatives of salicylanilide STD-NMR structure-activity relationship target identification thyroid diseases TMEM97 translocator protein (TSPO) UDP-galactopyranose mutase vascular homeostasis |
| Formato | Materiale a stampa  |
| Livello bibliografico | Monografia |
| Lingua di pubblicazione | eng |
| Altri titoli varianti |
Protein—Ligand Interactions
Protein-Ligand Interactions Protein–Ligand Interactions |
| Record Nr. | UNINA-9910557497703321 |
Altieri Fabio
|
||
| Basel, Switzerland, : MDPI - Multidisciplinary Digital Publishing Institute, 2021 | ||
| Materiale a stampa | ||
| Lo trovi qui: Univ. Federico II | ||
| ||
Role of Medical Imaging in Cancers
| Role of Medical Imaging in Cancers |
| Autore | Fanti Stefano |
| Pubbl/distr/stampa | Basel, Switzerland, : MDPI - Multidisciplinary Digital Publishing Institute, 2021 |
| Descrizione fisica | 1 online resource (312 p.) |
| Soggetto topico | Medicine |
| Soggetto non controllato |
18F-FACBC
18F-FDG PET/CT 68Gallium-PSMA PET/CT adipose tissue Adoptive biochemical recurrence biomarker biomarkers bladder cancer breast breast cancer castrate resistant prostate cancer CD8-Positive T-Lymphocytes circulating miRNAs circulating tumor cells computed tomography Computer-assisted diagnosis concurrent chemoradiotherapy consensus CTLA-4 Antigen cystic tumor DCFBC DCFPyL Deauville criteria diagnosis diagnostic imaging diffuse large B-cell lymphoma diffusion diffusion kurtosis imaging diffusion tensor imaging diffusion-weighted imaging dynamic 18F-FDG PET/CT dynamic contrast-enhanced magnetic resonance imaging EBV empyema epistemology FDG FDG-PET/CT follow up glioblastoma gold nanoparticle guidelines head and neck cancer head and neck neoplasms heat shock protein 70 Hodgkin lymphoma Hounsfield unit HPV imaging imaging parameters immune checkpoint inhibitors immunotherapy Immunotherapy International Consensus Guidelines intraductal papillary mucinous neoplasms locally advanced cervical cancer machine learning magnetic resonance imaging malignant pleural mesothelioma mantle cell lymphoma marker mCRPC meningioma Mesothelin meta-analysis metastatic breast cancer miRNA expression molecular imaging Molecular imaging MRI n/a neovascularization neuroimaging non-small-cell lung cancer noninvasive imaging NSCLC nuclear medicine optimal cutoff level ovarian cancer overutilization p16 pancreatic neoplasms pathologic pazopanib PD-1 PD-L1 PDAC PERCIST perfusion PET PET/CT PET/MRI PI-RADS pleural dissemination pleural effusion positron emission tomography positron-emission tomography precision oncology prognosis programmed cell death 1 receptor prostate prostate cancer prostate-specific-antigen PSA kinetics thresholds PSMA PSMA-1007 radiation therapy radioactive tracers radiogenomics radiomic radiomics radionuclide imaging radionuclide therapy Radium-223 receptor status recurrence relapse response assessment response to therapy response to treatment review sdAbs single-photon emission computed tomography soft tissue sarcoma (STS) somatostatin receptor SPECT imaging SPECT/CT spectral-CT squamous cell carcinoma of the head and neck staging survival SUV SUVmax targeted therapy texture analysis Therapy response assessment treatment response triple negative breast cancer two-tissue compartment model upper tract urothelial carcinoma urothelial carcinoma VCAM-1 XOFIGO Yin Yang 1 |
| Formato | Materiale a stampa |
| Livello bibliografico | Monografia |
| Lingua di pubblicazione | eng |
| Record Nr. | UNINA-9910557432103321 |
|
Fanti Stefano
|
||
| Basel, Switzerland, : MDPI - Multidisciplinary Digital Publishing Institute, 2021 | ||
| Materiale a stampa | ||
| Lo trovi qui: Univ. Federico II | ||
| ||
Role of Medical Imaging in Cancers
| Role of Medical Imaging in Cancers |
| Autore | Fanti Stefano |
| Pubbl/distr/stampa | Basel, Switzerland, : MDPI - Multidisciplinary Digital Publishing Institute, 2021 |
| Descrizione fisica | 1 online resource (228 p.) |
| Soggetto topico | Medicine and Nursing |
| Soggetto non controllato |
18F-FACBC
18F-FDG PET/CT 68Gallium-PSMA PET/CT adipose tissue Adoptive biochemical recurrence biomarker biomarkers bladder cancer breast breast cancer castrate resistant prostate cancer CD8-Positive T-Lymphocytes circulating miRNAs circulating tumor cells computed tomography Computer-assisted diagnosis concurrent chemoradiotherapy consensus CTLA-4 Antigen cystic tumor DCFBC DCFPyL Deauville criteria diagnosis diagnostic imaging diffuse large B-cell lymphoma diffusion diffusion kurtosis imaging diffusion tensor imaging diffusion-weighted imaging dynamic 18F-FDG PET/CT dynamic contrast-enhanced magnetic resonance imaging EBV empyema epistemology FDG FDG-PET/CT follow up glioblastoma gold nanoparticle guidelines head and neck cancer head and neck neoplasms heat shock protein 70 Hodgkin lymphoma Hounsfield unit HPV imaging imaging parameters immune checkpoint inhibitors immunotherapy Immunotherapy International Consensus Guidelines intraductal papillary mucinous neoplasms locally advanced cervical cancer machine learning magnetic resonance imaging malignant pleural mesothelioma mantle cell lymphoma marker mCRPC meningioma Mesothelin meta-analysis metastatic breast cancer miRNA expression molecular imaging Molecular imaging MRI n/a neovascularization neuroimaging non-small-cell lung cancer noninvasive imaging NSCLC nuclear medicine optimal cutoff level ovarian cancer overutilization p16 pancreatic neoplasms pathologic pazopanib PD-1 PD-L1 PDAC PERCIST perfusion PET PET/CT PET/MRI PI-RADS pleural dissemination pleural effusion positron emission tomography positron-emission tomography precision oncology prognosis programmed cell death 1 receptor prostate prostate cancer prostate-specific-antigen PSA kinetics thresholds PSMA PSMA-1007 radiation therapy radioactive tracers radiogenomics radiomic radiomics radionuclide imaging radionuclide therapy Radium-223 receptor status recurrence relapse response assessment response to therapy response to treatment review sdAbs single-photon emission computed tomography soft tissue sarcoma (STS) somatostatin receptor SPECT imaging SPECT/CT spectral-CT squamous cell carcinoma of the head and neck staging survival SUV SUVmax targeted therapy texture analysis Therapy response assessment treatment response triple negative breast cancer two-tissue compartment model upper tract urothelial carcinoma urothelial carcinoma VCAM-1 XOFIGO Yin Yang 1 |
| Formato | Materiale a stampa |
| Livello bibliografico | Monografia |
| Lingua di pubblicazione | eng |
| Record Nr. | UNINA-9910557309503321 |
|
Fanti Stefano
|
||
| Basel, Switzerland, : MDPI - Multidisciplinary Digital Publishing Institute, 2021 | ||
| Materiale a stampa | ||
| Lo trovi qui: Univ. Federico II | ||
| ||